Literature DB >> 11157154

Antiphospholipid antibody system in systemic sclerosis.

A Parodi, M Drosera, L Barbieri, A Rebora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11157154     DOI： 10.1093/rheumatology/40.1.111

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  Lower extremity ulcers in systemic sclerosis: features and response to therapy.

Authors:  Victoria K Shanmugam; Patricia Price; Christopher E Attinger; Virginia D Steen
Journal:  Int J Rheumatol       Date:  2010-08-18

2.  Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Int J Rheumatol       Date:  2010-08-17

3.  Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study.

Authors:  Sara R Schoenfeld; Hyon K Choi; Eric C Sayre; J Antonio Aviña-Zubieta
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-02       Impact factor: 4.794

4.  Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.

Authors:  Francesco Boin; Stefano Franchini; Elizabeth Colantuoni; Antony Rosen; Fredrick M Wigley; Livia Casciola-Rosen
Journal:  Arthritis Rheum       Date:  2009-08

5.  Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.

Authors:  Vincent Sobanski; Angélique Lemaire-Olivier; Jonathan Giovannelli; Luc Dauchet; Myriam Simon; Benjamin Lopez; Cécile Yelnik; Marc Lambert; Pierre-Yves Hatron; Eric Hachulla; Sylvain Dubucquoi; David Launay
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.